Table 2.
Demographic and Clinical Characteristics for Newly Diagnosed HIV Patients in 2002–2004 and 2008–2011
| Characteristic | 2002–2004 (n=113) | 2008–2011 (n=101) | p Value |
|---|---|---|---|
| Age | |||
| Mean±SD | 36.1±10 | 38.9±12.8 | 0.074 |
| Gender | |||
| Male | 82 (72.6%) | 67 (66.3%) | 0.323 |
| Female | 31 (27.4%) | 34 (33.7%) | |
| Race | |||
| Black | 62 (54.6%) | 73 (72.3%) | 0.008 |
| White | 35 (31.0%) | 20 (19.8%) | |
| Hispanic | 7 (6.3%) | 8 (7.9%) | |
| Unknown | 7 (6.2%) | 0 (0%) | |
| Other | 2 (1.9%) | 0 (0%) | |
| Insurance | |||
| Uninsured | 44 (38.9%) | 28 (27.7%) | 0.083 |
| Insured | 69 (61.1%) | 73 (72.3%) | |
| Mode of HIV acquisition | |||
| MSM | 33 (29.2%) | 24 (23.8%) | 0.369 |
| Heterosexual | 32 (28.3%) | 57 (56.4%) | |
| IVDU | 8 (7.1%) | 4 (4.0%) | |
| Othera/unknown | 40 (35.4%) | 16 (15.8%) | |
| Site of diagnosis | |||
| Outpatient | 54 (47.8%) | 73 (72.3%) | <0.001 |
| Inpatient | 39 (34.5%) | 28 (27.7%) | |
| Unknown | 20 (17.7%) | 0 (0%) | |
| Persons w/ OI at diagnosis | 20 (17.9%)b | 15 (14.9%)c | 0.574 |
| CD4 lymphocyte count | |||
| <200 cells/μL | 55 (48.7%) | 33 (32.7%) | 0.018 |
| HIV RNA | |||
| >100,000 copies/mL | 66 (58.9%) | 38 (37.6%) | 0.002 |
a
Other: transgender, bisexual; bopportunistic infections: CNS toxoplasmosis (n=1); cryptococcal meningitis (n=5); cryptosporidial diarrhea (n=1); Kaposi's sarcoma (n=1); lymphoma (n=2); Pneumocystis jirovecii pneumonia (n=9); progressive multifocal leukoencephalopathy (n=1). cOIs: CNS toxoplasmosis (n=1); cryptococcal meningitis (n=1); esophageal candidiasis (n=4); Mycobacterium avium complex (n=1); Pneumocystis jirovecii pneumonia (n=9); recurrent severe bacterial infections (n=1).